PADI1 and Its Co-Expressed Gene Signature Unveil Colorectal Cancer Prognosis and Immunotherapy Efficacy

Figure 2

Survival analysis of PADI1 in diverse clinical subgroups of CRC. (a) Survival analysis of PADI1 in CRC in the age subgroup; (b) survival analysis of PADI1 in CRC in the gender subgroup; (c) survival analysis of PADI1 in CRC in the tumor size subgroup; (d) survival analysis of PADI1 in CRC in the lymph node metastasis subgroup; (e) survival analysis of PADI1 in CRC in the distant metastasis subgroup; and (f) survival analysis of PADI1 in CRC in TNM staging subgroup.

(a)

(b)

(c)

(d)

(e)

(f)